We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9008:TSEKeio Corporation Analysis

Data as of 2026-06-14 - not real-time

MYR 0.07

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Omesti Berhad is trading at roughly half of its DCF‑derived fair value, with the current price of 0.07 MYR well below the estimated 0.12 MYR intrinsic value. Technicals are bearish: the 20‑day SMA sits just under the 50‑day SMA, the MACD histogram is negative and the trend direction is flagged as bearish, while RSI hovers around the mid‑40s, suggesting limited upside momentum. Volume is on the rise, yet the price is squeezed between a clear support around 0.07 and resistance near 0.08, leaving little room for a rally without a breakout. Fundamentally, the company reports negative margins, a trailing EPS of –3.73 and a debt load that dwarfs its cash reserves, resulting in a zero dividend payout and a PE ratio of zero. The sector—specialty business services—carries medium‑level industry risk, and the stock’s high 30‑day volatility (≈60%) amplifies short‑term uncertainty. Given these mixed signals, investors should treat the stock as a high‑risk, potentially undervalued play that may reward patient capital if a turnaround can be achieved.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and SMA crossover
  • Price hovering at support with limited upside
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant undervaluation versus DCF fair value
  • Increasing trading volume indicating potential buyer interest
  • Need for earnings and margin improvement

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Strategic exposure to growing digital and infrastructure services in SE Asia
  • Potential restructuring to reduce debt and improve cash flow
  • Long‑term sector tailwinds for specialty business services

Key Metrics & Analysis

Financial Health

Revenue Growth-19.20%
Profit Margin-95.70%
Debt/Equity48.42
P/B Ratio0.2
Op. Cash FlowMYR34.8M
Industry P/E30.6

Technical Analysis

TrendBearish
RSI42.8
SupportMYR 0.07
ResistanceMYR 0.08
MA 20MYR 0.07
MA 50MYR 0.07
MA 200MYR 0.08
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueMYR 0.12
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.41
Volatility60.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.